Stockholm - Delayed Quote SEK

Clinical Laserthermia Systems AB (publ) (CLS-B.ST)

17.18 -1.15 (-6.27%)
At close: April 26 at 5:29 PM GMT+2
Key Events
Loading Chart for CLS-B.ST
DELL
  • Previous Close 18.33
  • Open 18.35
  • Bid 17.00 x --
  • Ask 17.18 x --
  • Day's Range 16.33 - 19.40
  • 52 Week Range 14.40 - 79.93
  • Volume 30,435
  • Avg. Volume 45,050
  • Market Cap (intraday) 145.149M
  • Beta (5Y Monthly) 0.48
  • PE Ratio (TTM) 0.17
  • EPS (TTM) 100.95
  • Earnings Date May 17, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 60.00

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.

www.clinicallaser.se

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLS-B.ST

Performance Overview: CLS-B.ST

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CLS-B.ST
37.75%
OMX Stockholm 30 Index
6.65%

1-Year Return

CLS-B.ST
76.81%
OMX Stockholm 30 Index
13.72%

3-Year Return

CLS-B.ST
90.75%
OMX Stockholm 30 Index
14.13%

5-Year Return

CLS-B.ST
96.26%
OMX Stockholm 30 Index
51.39%

Compare To: CLS-B.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLS-B.ST

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    134.89M

  • Enterprise Value

    104.90M

  • Trailing P/E

    0.17

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    14.14

  • Price/Book (mrq)

    2.11

  • Enterprise Value/Revenue

    12.93

  • Enterprise Value/EBITDA

    -2.06

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -77.72%

  • Return on Equity (ttm)

    -314.73%

  • Revenue (ttm)

    8.27M

  • Net Income Avi to Common (ttm)

    -79.79M

  • Diluted EPS (ttm)

    100.95

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.33M

  • Total Debt/Equity (mrq)

    3.84%

  • Levered Free Cash Flow (ttm)

    -46M

Research Analysis: CLS-B.ST

Analyst Price Targets

60.00
60.00 Average
17.18 Current
60.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: CLS-B.ST

People Also Watch